MX2017000878A - Peptidos marinos y nucleotidos de pescado, composiciones y sus usos para reducir la glucosa en la sangre. - Google Patents
Peptidos marinos y nucleotidos de pescado, composiciones y sus usos para reducir la glucosa en la sangre.Info
- Publication number
- MX2017000878A MX2017000878A MX2017000878A MX2017000878A MX2017000878A MX 2017000878 A MX2017000878 A MX 2017000878A MX 2017000878 A MX2017000878 A MX 2017000878A MX 2017000878 A MX2017000878 A MX 2017000878A MX 2017000878 A MX2017000878 A MX 2017000878A
- Authority
- MX
- Mexico
- Prior art keywords
- subject
- compositions
- blood glucose
- reducing blood
- blood
- Prior art date
Links
- 239000008280 blood Substances 0.000 title abstract 4
- 210000004369 blood Anatomy 0.000 title abstract 4
- 241000251468 Actinopterygii Species 0.000 title abstract 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title abstract 3
- 239000008103 glucose Substances 0.000 title abstract 3
- 239000002773 nucleotide Substances 0.000 title abstract 3
- 125000003729 nucleotide group Chemical group 0.000 title abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 235000012054 meals Nutrition 0.000 abstract 2
- 230000000291 postprandial effect Effects 0.000 abstract 2
- 101800001586 Ghrelin Proteins 0.000 abstract 1
- 102000012004 Ghrelin Human genes 0.000 abstract 1
- 239000012503 blood component Substances 0.000 abstract 1
- GNKDKYIHGQKHHM-RJKLHVOGSA-N ghrelin Chemical compound C([C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CN)COC(=O)CCCCCCC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C1=CC=CC=C1 GNKDKYIHGQKHHM-RJKLHVOGSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
- A23L17/20—Fish extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/13—Nucleic acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/612—Crustaceans, e.g. crabs, lobsters, shrimps, krill or crayfish; Barnacles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Diabetes (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Marine Sciences & Fisheries (AREA)
- Immunology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Microbiology (AREA)
- Insects & Arthropods (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Emergency Medicine (AREA)
- Biochemistry (AREA)
- Pediatric Medicine (AREA)
- Child & Adolescent Psychology (AREA)
Abstract
Se proporciona aquí un método para reducir las concentraciones postprandiales de glucosa en la sangre de un sujeto, que comprende administrar al sujeto, antes o durante una comida, una cantidad eficaz de una combinación de un péptido marino y un nucleótido de pescado, suficiente para reducir la concentración de glucosa en la sangre del sujeto. También se proporciona aquí un método para reducir la concentración postprandial de grelina en la sangre de un sujeto, que comprende administrar al sujeto, antes o durante una comida, una cantidad eficaz de una combinación de un péptido marino y un nucleótido de pescado suficiente para aumentar el componente sanguíneo en donde la combinación es administrada al sujeto.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462031855P | 2014-07-31 | 2014-07-31 | |
| PCT/EP2015/067451 WO2016016350A1 (en) | 2014-07-31 | 2015-07-30 | Marine peptides and fish nucleotides, compositions and uses thereof for reducing blood glucose |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2017000878A true MX2017000878A (es) | 2017-05-04 |
Family
ID=53773438
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2017000878A MX2017000878A (es) | 2014-07-31 | 2015-07-30 | Peptidos marinos y nucleotidos de pescado, composiciones y sus usos para reducir la glucosa en la sangre. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US10213473B2 (es) |
| EP (1) | EP3174548B1 (es) |
| JP (1) | JP6829186B2 (es) |
| CN (1) | CN106573034B (es) |
| BR (1) | BR112017001589A2 (es) |
| ES (1) | ES2815351T3 (es) |
| MX (1) | MX2017000878A (es) |
| RU (1) | RU2713935C1 (es) |
| WO (1) | WO2016016350A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021083958A1 (en) * | 2019-10-29 | 2021-05-06 | Specialites Pet Food | Novel peptides inducing satiety |
| FR3141617A1 (fr) * | 2022-11-08 | 2024-05-10 | Laboratoire Dielen | Composition pour son utilisation dans le traitement d’un syndrome de l'intestin irritable et/ou dans le traitement d’une hyperperméabilité intestinale. |
| WO2024117916A1 (en) * | 2022-12-01 | 2024-06-06 | Calanus As | Bioactive peptide fraction and its use in enhancing muscle growth |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0198445A (ja) * | 1987-10-12 | 1989-04-17 | Kanebo Ltd | 経口摂食組成物 |
| JP2764276B2 (ja) * | 1988-09-06 | 1998-06-11 | 仙味エキス株式会社 | 機能性新規ペプチド及びその利用 |
| JPH111495A (ja) * | 1997-06-10 | 1999-01-06 | Horiuchi Shokuhin Kogyo Kk | アマノリ属海藻からのポリペプチドの製造方法 |
| JP4862235B2 (ja) * | 2001-02-27 | 2012-01-25 | Ｊｎｃ株式会社 | 血糖値上昇抑制剤 |
| JP2002338482A (ja) * | 2001-05-22 | 2002-11-27 | Hayashikane Sangyo Kk | インシュリン抵抗性改善剤、及び、インシュリン抵抗性改善用食品、飲料及び錠剤 |
| NO315184B1 (no) * | 2001-09-26 | 2003-07-28 | Firmenich & Cie | Anvendelse av en sammensetning basert på fiskemelke for fremstilling av etpreparat som öker immunoglobulinproduksjonen |
| NO320667B1 (no) * | 2004-02-02 | 2006-01-16 | Einar Lied | Andvendelse av en sammensetning basert på fiskekjøtt for fremstilling av et preparat som reduserer økningen i blodglukose etter fødeinntak |
| WO2006026682A2 (en) | 2004-08-30 | 2006-03-09 | Hunter Douglas Inc. | Apparatus, software and method for controlling the operation of a window covering |
| GB0717911D0 (en) * | 2007-09-14 | 2007-10-24 | Univ Stirling | Vaccine |
| FR2927335B1 (fr) * | 2008-02-12 | 2012-04-20 | Cie Des Peches Saint Malo Sante | Hydrolysat de proteines de poissons presentant une activite satietogene, compositions nutraceutiques et pharmacologiques comprenant un tel hydrolysat et procede d'obtention |
| JP4750213B1 (ja) * | 2010-05-21 | 2011-08-17 | 株式会社 ファイナルフューチャーインターナショナル | アディポネクチン産生促進組成物 |
-
2015
- 2015-07-30 US US15/329,953 patent/US10213473B2/en active Active
- 2015-07-30 MX MX2017000878A patent/MX2017000878A/es unknown
- 2015-07-30 WO PCT/EP2015/067451 patent/WO2016016350A1/en not_active Ceased
- 2015-07-30 EP EP15745185.7A patent/EP3174548B1/en active Active
- 2015-07-30 RU RU2017106241A patent/RU2713935C1/ru active
- 2015-07-30 JP JP2017505501A patent/JP6829186B2/ja active Active
- 2015-07-30 CN CN201580039721.6A patent/CN106573034B/zh active Active
- 2015-07-30 BR BR112017001589-7A patent/BR112017001589A2/pt not_active IP Right Cessation
- 2015-07-30 ES ES15745185T patent/ES2815351T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| RU2713935C1 (ru) | 2020-02-11 |
| EP3174548B1 (en) | 2020-07-22 |
| US10213473B2 (en) | 2019-02-26 |
| ES2815351T3 (es) | 2021-03-29 |
| CN106573034B (zh) | 2021-12-17 |
| WO2016016350A1 (en) | 2016-02-04 |
| JP2017523203A (ja) | 2017-08-17 |
| JP6829186B2 (ja) | 2021-02-10 |
| BR112017001589A2 (pt) | 2018-01-30 |
| EP3174548A1 (en) | 2017-06-07 |
| US20170258866A1 (en) | 2017-09-14 |
| CN106573034A (zh) | 2017-04-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12013501877A1 (en) | Nutritional compositions including branched chain fatty acids and methods of using same | |
| PH12018501969A1 (en) | Pharmaceutical composition comprising empagliflozin and uses thereof | |
| HRP20220692T1 (hr) | Brzodjelujući pripravci inzulina | |
| EA201490393A1 (ru) | Соматотропный гормон пролонгированного действия и способы его получения | |
| IN2014MN02089A (es) | ||
| WO2015105981A3 (en) | Nutritional composition comprising hmb for increasing or maintaining lean body mass in subjects having reduced leucine to hmb conversion efficiency or undergoing diabetic treatment | |
| RU2017116973A (ru) | Способы применения и композиции нейрегулинов для предотвращения, лечения или замедления сердечной недостаточности с сохраненной фракцией выброса | |
| MY182593A (en) | Composition containing chitin and digestible proteins | |
| IN2014DN06920A (es) | ||
| EA201691420A1 (ru) | Композиции енолазы 1 (eno1) и их применение | |
| EA201790223A1 (ru) | Водный препарат, содержащий парацетамол и ибупрофен | |
| MX2023005014A (es) | Metodos de tratamiento de enfermedades inflamatorias cronicas. | |
| MX2018008299A (es) | Metodos para administrar hepcidina. | |
| WO2017029558A3 (en) | Methods for improving health of farmed fish | |
| EA201491369A1 (ru) | Способ лечения сахарного диабета при помощи негликозилированного аполипопротеина a-iv | |
| AU2016216741A1 (en) | Compositions and methods of use of an inappetance-controlling compound | |
| MX2017004662A (es) | Composiciones y metodos para mejorar la movilidad o actividad o tratar la fragilidad. | |
| NZ754706A (en) | Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus | |
| MX2017000878A (es) | Peptidos marinos y nucleotidos de pescado, composiciones y sus usos para reducir la glucosa en la sangre. | |
| WO2015168488A3 (en) | Islet amyloid polypeptides with improved solubility | |
| PH12016501554A1 (en) | Anticancer adjuvant composition containing rip3 expression promoter as active ingredient, method for screening for anticancer adjuvant enhancing sensitivity of anticancer drug by promoting rip3 expression, and method for monitoring sensitivity of anticancer drug | |
| MX2016012722A (es) | Metodos para tratar el virus de la hepatitis c. | |
| MX2017003217A (es) | Tratamiento del cancer con el inhibidor de la alfa-amilasa en los animales de compañía. | |
| PE20160847A1 (es) | Nuevo compuesto para el tratamiento de hipoglicemia severa | |
| IN2014DN09240A (es) |